Skip to main content
Clinical Trials/NCT05077163
NCT05077163
Unknown
Not Applicable

Renal Assessment of Patients With Acute Renal Failure During Severe COVID-19

University Hospital, Strasbourg, France1 site in 1 country40 target enrollmentDecember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal Failure Chronic
Sponsor
University Hospital, Strasbourg, France
Enrollment
40
Locations
1
Primary Endpoint
Retrospective study of renal development in patients with acute renal failure during severe COVID-19
Last Updated
4 years ago

Overview

Brief Summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known.

The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Registry
clinicaltrials.gov
Start Date
December 1, 2020
End Date
December 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retrospective study of renal development in patients with acute renal failure during severe COVID-19

Time Frame: Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]

Study Sites (1)

Loading locations...

Similar Trials